Agents and Actions

, Volume 5, Issue 2, pp 164–173 | Cite as

Protective action of ascorbic acid and sulfur compounds against acetaldehyde toxicity: Implications in alcoholism and smoking

  • Herbert Sprince
  • Clarence M. Parker
  • George G. Smith
  • Leon J. Gonzales
Models in Toxicology Review


Acetaldehyde is a toxic substance common to heavy drinking of alcohol and heavy smoking of cigarettes. It has been implicated thereby in diseases of the cardiovascular, respiratory, and central nervous systems. Protection against acetaldehyde toxicity (i.e. anesthesia and lethality) was studied in rats by oral intubation of test compounds 30–45 minutes prior to oral intubation of a standardized oral LD 90 dose (18 millimoles/kologram) of acetaldehyde. Animals were monitored for anesthesia (loss of righting reflexes) and lethality for 72 hours. A total of 18 compounds was tested.l-ascorbic acid at 2 millimoles/kilogram (mM/kg) showed moderate protection against anesthesia and marked protection against lethality. Greatest protection against anesthesia and lethality was obtained at 2 mM/kg with each of the following:l-cysteine N-acetyl-l-cysteine, thiamin HCl, sodium metabisulfite, andl-cysteic acid. A combination ofl-ascorbic acid withl-cysteine, and thiamin·HCl at reduced dose levels (2.0, 1.0 and 0.3 mM/kg, respectively) gave virtually complete protection. A detailed literature review is presented of the rationale and significance of these findings. Our findings could point the way to a possible build-up of natural protection against the chronic body insult of acetaldehyde arising from heavy drinking of alcohol and heavy smoking of cigarettes.


Thiamin Heavy Drinking Heavy Smoking Natural Protection Metabisulfite 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    H. Sprince, C.M. Parker, G.G. Smith andL.J. Gonzales,Protection against Acetaldehyde Toxicity in the Rat by l-Cysteine, Thiamin, andl-2-Methylthiazolidine-4-Carboxylic Acid, Agents and Actions4, 125–130 (1974).CrossRefPubMedGoogle Scholar
  2. [2]
    H. Sprince, C.M. Parker, G.G. Smith, andL.J. Gonzales,Protectants against Acetaldehyde Toxicity: Sulfhydryl Compounds and Ascorbic Acid, Fed. Proc. Fed. Am. Soc. exp. Biol.33, No. 3, part 1, 233, Abstract No. 172 (1974).Google Scholar
  3. [3]
    H. Sprince, C.M. Parker, G.G. Smith andL.J. Gonzales,Protection against Acetaldehyde Toxicity and Lethality by l-Cysteine Plus Thiamin, Fed. Proc. Fed. Am. Soc. exp. Biol.31, No. 2, 574, Abstract No. 2025 (1972).Google Scholar
  4. [4]
    T.N. James, E.S. Bear, K.F. Lang, E.W. Green andH.H. Winkler,Adrenergic Mechanisms in the Sinus Node, Arch. Int. Med.125, 512–547 (1970).CrossRefGoogle Scholar
  5. [5]
    E.B. Truitt, Jr., andM.J. Walsh,The Role of Acetaldehyde in the Actions of Ethanol, in:The Biology of Alcoholism, vol. 1, chapter 5 (Eds B. Kissin and H. Begleiter; Plenum Press, New York 1971), p. 161–195.Google Scholar
  6. [6]
    E. Majchrowicz andJ.H. Mendelson,Blood Concentrations of Acetaldehyde and Ethanol in Chronic Alcoholics, Science168, 1100–1102 (1970).PubMedGoogle Scholar
  7. [7]
    A.D. Horton andM.R. Guerin,Determination of Acetaldehydes and Acrolein in the Gas Phase of Cigarette Smoke Using Cryothermal Gas Chromatography, Tobacco176 (4), 45–48 (1974).Google Scholar
  8. [8]
    R. Rylander,Toxicity of Cigarette Smoke Components: Free Lung Cell Response in Acute Exposures, Am. Rev. resp. Dis.108, 1279–1282 (1973).PubMedGoogle Scholar
  9. [9]
    J.L. Egle, Jr.,Retention of Inhaled Acetaldehyde in Man, J. exp. Pharm. Exp. Ther.174, 14–19 (1970).Google Scholar
  10. [10]
    B.M. Maletzky andJ. Klotter,Smoking and Alcoholism, Am. J. Psychiat.131, 445–447 (1974).PubMedGoogle Scholar
  11. [11]
    R.G. Walton,Smoking and Alcoholism: A Brief Report, Am. J. Psychiat.128, 1455–1459 (1972).PubMedGoogle Scholar
  12. [12]
    S.S. Schreiber, M. Oratz, M.A. Rothschild, F. Reff andC. Evans,Alcoholic Cardiomyopathy II. The Inhibition of Cardiac Microsomal Protein Synthesis by Acetaldehyde, J. Mol. Cell Cardiol.6, 207–213 (1974).CrossRefPubMedGoogle Scholar
  13. [13]
    T.N. James andE.S. Bear,Cardiac Effects of some Simple Aliphatic Aldehydes, J. Pharmac. exp. Ther.163, 300–308 (1968).Google Scholar
  14. [14]
    T. N. James andE.S. Bear,Effects of Ethanol and Acetaldehyde on the Heart, Am. Heart J.74, 243–255 (1967).CrossRefPubMedGoogle Scholar
  15. [15]
    V.E. Davis andM.J. Walsh,Alcohol, Amines, and Alkaloids: A Possible Biochemical Basis for Alcohol Addiction, Science167, 1005–1007 (1970).PubMedGoogle Scholar
  16. [16]
    G. Cohen andM. Collins,Alkaloids from Catecholamines in Adrenal Tissue: Possible Role in Alcoholism, Science167, 1749–1751 (1970).PubMedGoogle Scholar
  17. [17]
    J.A. Ewing, B.A. Rouse andE.D. Pellizzari,Alcohol Sensitivity and Ethnic Background, Am. J. Psychiat.131, 206–210 (1974).PubMedGoogle Scholar
  18. [18]
    P.M. Dreyfus,Diseases of the Nervous System in Chronic Alcoholics, in:The Biology of Alcoholism, vol. 3, chapter 7 (Eds. B. Kissin and H. Begleiter; Plenum Press, New York 1974), p. 265–290.Google Scholar
  19. [19]
    J. Bjorksten,The Crosslinkage Theory of Aging, Finska Kemists Medd.80, No. 2, 23–28 (Suomen Kemists Tied 1971).Google Scholar
  20. [20]
    A. Weissman andB.K. Koe,Drugs and Deterrence of Alcohol Consumption, Annual Reports in Medicinal Chemistry 1968, chapter 22 (Ed. C.K. Cain; Academic Press, New York 1969), p. 246–258.Google Scholar
  21. [21]
    E.W. Martin,Hazards of Medication (J. B. Lippincott Co., Philadelphia 1971), p. 430–439.Google Scholar
  22. [22]
    A.S. Banner,Pulmonary Function in Chronic Alcoholism, Am. Rev. resp. Dis.108, 851–857 (1973)PubMedGoogle Scholar
  23. [23]
    G.E. Burch andN.P. DePasquale,Alcoholic Lung Disease-An Hypothesis, Am. Heart J.73, 147–148 (1967).CrossRefPubMedGoogle Scholar
  24. [24]
    H. Casier,Accumulation of Alcohol Metabolites in the Form of Total Lipids and Fatty Acids in the Organism. Studies in Mice after Administration of Daily and Repeated Doses of Radiocative Ethanol, Quart. J. Stud. Alc.23, 529–548 (1962).Google Scholar
  25. [25]
    R. Guillerm, R. Badre andB. Vignon,Effets inhibiteurs de la fumée de tabac sur l'activité ciliaire de l-épithilium respiratoire et nature des composants responsables, Bull. Acad. Nat. Med.145, 416–423 (1961).Google Scholar
  26. [26]
    O. Auerbach, A.P. Stout, E.C. Hammond andL. Garfinkel,Changes in Bronchial Epithelium in Relation to Cigarette Smoking and in Relation to Lung Cancer, New Engl. J. Med.265, 265–267 (1961).Google Scholar
  27. [27]
    J.J. Ballenger,Experimental Effect of Cigarette Smoke on Human Respiratory Cilia, New Engl. J. Med.263, 832–835 (1960).PubMedGoogle Scholar
  28. [28]
    G. Niblo, W.W. Nowinski andD. Roark,Effects of Ascorbic Acid in Antabuse-Alcohol Reactions, Dis. nerv. Syst.12, 340–343 (1951).PubMedGoogle Scholar
  29. [29]
    J.D. Markham andE.C. Hoff,Toxic Manifestations in the Antabuse-Alcohol Reaction, J. Am. Med. Ass.152, 1597–1600 (1953).Google Scholar
  30. [30]
    Physicians' Desk Reference, 28th ed. (Publ. C.E. Baker, Jr.; Med. Economics Co., Oradell, New Jersey 1974), p. 575–576.Google Scholar
  31. [31]
    A. Lemoine, A. Monges, J.-L. Codaccioni, P. Bermond andW.F. Koerner,Alcoolisme chronique et vitamines (Chronic Alcoholism and Vitamins), Revue Alcool.18, 273–291 (1972).Google Scholar
  32. [32]
    V.K.H. Ibragimov,Nekotoryye Brokhimicheskiye Pokazateli Krovi Pri Khronicheskom Alkagolizme (Some Biochemical Indices in the Blood in Chronic Alcoholism), Vrachebnoe Delo (Kiev)6, 134–135 (1967).Google Scholar
  33. [33]
    D. Lester, R. Buccino andD. Bizzocco,The Vitamin C Status of Alcoholics, J. Nutr.70, 278–282 (1960).PubMedGoogle Scholar
  34. [34]
    H. Wortis, S.B. Wortis andF.I. Marsh,Vitamin C Studies in Alcoholics, Am. J. Psychiat.94, 891–912 (1938).Google Scholar
  35. [35]
    A.K. Sim,Ascorbic Acid-A Survey, Past and Present, Chem. Indust.8, 160–165 (1972).Google Scholar
  36. [36]
    O. Pelletier,Vitamin C Status of Cigarette Smokers and Nonsmokers, Am. J. Clin. Nutr.23, 520–524 (1970).PubMedGoogle Scholar
  37. [37]
    S. Sament,Cardiac Disorders in Scurvy (Letter of the Editor), New Engl. J. Med.282 282–283 (1970).Google Scholar
  38. [38]
    J. Shafar,Rapid Reversion of Electrocardiographic Abnormalities after Treatment in Two Cases of Scurvy, Lancet2, 176–178 (1967).CrossRefPubMedGoogle Scholar
  39. [39]
    H.S. Loh,Mortality from Atherosclerosis and Vitamin-C Intake, Lancet2, 153 (1973).CrossRefGoogle Scholar
  40. [40]
    C.R. Spittle,Vitamin C and Deep-Vein Thrombosis, Lancet2, 199–201 (1973).CrossRefGoogle Scholar
  41. [41]
    S. Kaufman,Coenzymes and Hydroxylases: Ascorbate and Dopamine-β-Hydroxylase; Tetrahydropteridines and Phenylalanine and Tyrosine Hydroxylases, Pharmac. Rev.18, 61–69 (1966).Google Scholar
  42. [42]
    M.H. Bilimoria andM.A. Nisbet,Effect of Tobacco Smoke Condensates on Ascorbate, Beitr. Tabakforsch.6(1), 32–35 (July 1971).Google Scholar
  43. [43]
    J. Akabane,Aldehydes and Related Compounds, in:International Encyclopedia of Pharmacology and Therapeutics, vol. II (Ed. J. Trémolières; Pergamon Press, New York 1970), p. 523–560.Google Scholar
  44. [44]
    G.M. Green,Cigarette Smoke: Protection of Alveolar Macrophages by Glutathione and Cysteine, Science162, 810–811 (1968).PubMedGoogle Scholar
  45. [45]
    G.M. Powell andG. M. Green,Cigarette Smoke — A Proposed Metabolic Lesion in Alveolar Macrophages, Biochem. Pharmac.21, 1785–1798 (1972).CrossRefGoogle Scholar
  46. [46]
    H. Weiner, P. King, J.H.J. Hu andW.R. Bensch,Mechanistic and Enzymatic Properties of Liver Aldehyde Dehydrogenases, in:Alcohol and Aldehyde Metabolizing Enzymes (Eds R. G. Thurman, T. Yonetani, J. R. Williamson and B. Chance; Academic Press, Inc. 1974), p. 101–113.Google Scholar
  47. [47]
    M. Friedman,The Chemistry and Biochemistry of the Sulfhydryl Group in Amino Acids, Peptides, and Proteins (Pergamon Press, New York 1973), p. 88–90, 92–95.Google Scholar
  48. [48]
    H.J. Debey, J.B. Mackenzie andC.G. Mackenzie,The Replacement by Thiazolidinecarboxylic Acid of Exogenous Cystine and Cysteine, J. Nutr.66, 607–619 (1958).PubMedGoogle Scholar
  49. [49]
    G.J. Martin, J.N. Moss, R.D. Smyth andH. Beck,The Effect of Cysteine in Modifying the Action of Ethanol Given Chronically in Rats, Life Sci.5, 2357–2362 (1966).CrossRefPubMedGoogle Scholar
  50. [50]
    M. Friedman,The Chemistry and Biochemistry of the Sulfhydryl Group in Amino Acids, Peptides, and Proteins (Pergamon Press, New York 1973), p. 418.Google Scholar
  51. [51]
    Physicians' Desk Reference, 28th ed. (Pub. C.E. Baker, Jr.; Med. Economics Co., Oradell, New Jersey 1974), p. 981.Google Scholar
  52. [52]
    J.G. Jacobsen andL.H. Smith, Jr.,Biochemistry and Physiology of Taurine and Taurine Derivatives, Physiol. Rev.48, 424–511 (1968).PubMedGoogle Scholar
  53. [53]
    W.O. Read andJ.D. Welty,Taurine as a Regulator of Cell Potassium in the Heart, in:Electrolytes and Cardiovascular Diseases, vol. 1 (Ed. E. Bajusz; S. Karger Basel-New York 1965), p. 70–85.Google Scholar
  54. [54]
    R.E. Olson,Nutrition and Alcoholism, in:Modern Nutrition in Health and Disease (Eds M. G. Wohl and R. S. Goodhart; Lea and Febiger 1968), p. 767–781.Google Scholar
  55. [55]
    P.A. Tomasulo, R.M.H. Kater andF.L. Iber,Impairment of Thiamin Absorption in Alcoholism, Am. J. Clin. Nutr.21, 1341–1344 (1968).PubMedGoogle Scholar
  56. [56]
    G.E. Burch andT.D. Giles,Alcoholic Cardiomyopathy, in:The Biology of Alcoholism, vol. 3, chapter 13 (Eds B. Kissin and H. Begleiter; Plenum Press, New York 1974), p. 435–460.Google Scholar
  57. [57]
    W.C. Hueper,Experimental Studies in Cardiovascular Pathology. VIII. Chronic Nicotine Poisoning in Rats and in Dogs, Arch. Path.35, 846–856 (1943).Google Scholar
  58. [58]
    T. Matsukawa andS. Yurugi,On a New Derivative of Thiamine with Cysteine, Science118, 109–111 (1953).PubMedGoogle Scholar
  59. [59]
    B. Vennesland andE.E. Conn,The Enzymatic Oxidation and Reduction of Glutathione, in:Glutathione, A Symposium (Eds S. Colowick et al.; Academic Press, New York 1954), p. 105–127.Google Scholar
  60. [60]
    Z.G. Bánhidi,Thiamine-Sparing Action of Ascorbic Acid on some Lactobacilli and the Rat Due to Thiamine Disulfide Activation, Ann. N.Y. Acad. Sci.92, 324–332 (1961).PubMedGoogle Scholar
  61. [61]
    Z.G. Bánhidi,Molecular Physiology of Thiamine, Acta physiol. scand.50, Suppl. 174 (20 p.) (1960).Google Scholar
  62. [62]
    D.S. Murdock, M.L. Donaldson andC.J. Gubler,Studies on the Mechanism of the ‘Thiamin-Sparing’ Effect of Ascorbic Acid in Rats, Am. J. Clin. Nutr.27, 696–699 (1974).PubMedGoogle Scholar
  63. [63]
    M. Fujiwara, H. Nanjo, T. Arai andJ. Suzuoki,Allithiamine, a Derivative of Vitamin B 1.II. Effect of Allithiamine on the Living Organism, J. Biochem. (Japan)41, 273–285 (1954).Google Scholar
  64. [64]
    D. Hioco, R. Tixier andA. Uzan,Biochemical Investigation of Thiamin Propyl Disulfide. Its Transformation in vivo into Cocarboxylase, Bull. Soc. Chim. Biol.41, 1075–1083 (1959).PubMedGoogle Scholar
  65. [65]
    A.D. Thomson, O. Frank, H. Baker andC. M. Leevy,Thiamin Propyl Disulfide: Absorption and Utilization, Ann. Int. Med.74, 529–534 (1971).PubMedGoogle Scholar
  66. [66]
    G.I. Yezriyelev,Atsetal'degid i alkogolizm; farmakogenez Teturamalkogol'noi reaktsii i upravleniye eyu putem svyazyvaniya atsetal'degida metabisul'fitom natriya (Acetaldehyde and Alcoholism; Pharmacogenesis of the Teturam-Alcohol Reaction and Its Control through Compound Formation between Acetaldehyde and Sodium Metabisulfite), Zh. Nevropat. Psikhiat.73, 238–243 (1973).Google Scholar
  67. [67]
    F.P. Turner andV.C. Brum,The Urinary Excretion of Free Taurine in Acute and Chronic Disease, Following Surgical Trauma, and in Patients with Acute Alcoholism, J. Surg. Res.4, 423–431 (1964).Google Scholar
  68. [68]
    T.J. Regan,Ethyl Alcohol and the Heart, Circulation44, 957–963 (1971).PubMedGoogle Scholar
  69. [69]
    D.G. Spaeth andD.L. Schneider,Turnover of Taurine in Rat Tissues, J. Nutr.104, 179–186 (1974).PubMedGoogle Scholar
  70. [70]
    N.H. Raskin andL. Sokoloff,Enzymes Catalysing Ethanol Metabolism in Neural and Somatic Tissues of the Rat, J. Neurochem.19, 273–282 (1972).PubMedGoogle Scholar
  71. [71]
    R.A. Deitrich,Tissue and Subcellular Distribution of Mammalian Aldehyde-Oxidizing Capacity, Biochem. Pharmac.15, 1911–1922 (1966).CrossRefGoogle Scholar
  72. [72]
    H.P.T. Ammon,Discussion on Pages 226–227 of Paper by E.G. Truitt, Jr., Entitled Blood Acetaldehyde Levels after Alcohol Consumption by Alcoholic and Nonalcoholic Subjects, in:Biological Aspects of Alcohol, chapter 9 (Eds M.K. Roach, W.M. McIsaac and P.J. Creaven; University of Texas Press, Austin 1971), p. 212–232.Google Scholar
  73. [73]
    E.B. Truitt,Ethanol-Induced Release of Acetaldehyde from Blood and Its Effect on the Determination of Acetaldehyde, Q. J. Stud. Alcohol31, 1–12 (1970).PubMedGoogle Scholar
  74. [74]
    S. Gudbjarnason andA.S. Prasad,Cardiac Metabolism in Experimental Alcoholism, in:Biochemical and Clinical Aspects of Alcohol Metabolism, chapter 26 (Ed. V.M. Sardesai; Charles C. Thomas, Springfield 1969), p. 266–272.Google Scholar
  75. [75]
    H.P.T. Ammon, C.-J. Estler andF. Heim,Effect of Alcohol and Acetaldehyde on Coenzyme A, in:Biological Aspects of Alcohol, chapter 8 (Eds M.K. Roach, W.M. McIsaac and P.J. Creaven; University of Texas Press, Austin 1971), p. 185–211.Google Scholar
  76. [76]
    E. Rubin andA.I. Cederbaum,Effects of Chronic Ethanol Feeding and Acetaldehyde on Mitochondrial Functions and the Transfer of Reducing Equivalents, in:Alcohol and Aldehyde Metabolizing Systems (Eds R.G. Thurman, T. Yonetani, J.R. Williamson and B. Chance; Academic Press, New York 1974), p. 435–455.Google Scholar
  77. [77]
    A. Mohammad, H.S. Olcott andH. Fraenkel-Conrat,The Reaction of Proteins with Acetaldehyde, Arch. Biochem.24, 270–280 (1949).PubMedGoogle Scholar
  78. [78]
    H. Eagle,Some Effects of Formaldehyde on Horse Antipneumococcus Serum and Diphteria Antitoxin, and Their Significance for the Theory of Antigen-Antibody Aggregation, J. Exp. Med.67, 495–514 (1938).CrossRefGoogle Scholar
  79. [79]
    E.A. Kabat andM.M. Mayer,Experimental Immunochemistry, 2nd ed. (C.C. Thomas, Springfield, Illinois 1961), p. 350.Google Scholar
  80. [80]
    E.A. Kabat andM.M. Mayer,Experimental Immunochemistry, 2nd ed. (C.C. Thomas, Springfield, Illinois 1961), p. 459–461.Google Scholar
  81. [81]
    L.F. Hewitt,Note on Possible Mechanism of Diphtheria Toxoid Formation, Biochem. J., Lond.24, 983–992 (1930).Google Scholar

Copyright information

© Birkhäuser Verlag 1975

Authors and Affiliations

  • Herbert Sprince
    • 2
    • 1
  • Clarence M. Parker
    • 2
    • 1
  • George G. Smith
    • 2
    • 1
  • Leon J. Gonzales
    • 2
    • 1
  1. 1.U.S. Veterans Administration HospitalCoatesvilleUSA
  2. 2.The Departments of Psychiatry and Human Behavior and Pharmacology, Jefferson Medical CollegeThomas Jefferson UniversityPhiladelphiaUSA

Personalised recommendations